The Neuroendocrine System OF the Gut—AN Update

References

• Sundler F, Håkanson R. Peptide hormone-producing endocrine/paracrine cells in the gastro-entero-pancreatic region. Handbook of Chemical Neuroanatomy, A Björklund, T Hökfelt, C Owman. The Peripheral Nervous System. Elsevier Science Publishers, 1988; Vol. 6: 219–95
   Google Scholar
• Håkanson R, Sundler F. Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis. Eur J Clin Invest 1990; 20: 65–71, Suppl 1
   PubMed Web of Science ®Google Scholar
• Larsson H, Carlsson E, Mattsson H, et al. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrec-tomized rats. Gastroenterology 1986; 90: 391–9
   PubMed Web of Science ®Google Scholar
• Sundler F, Håkanson R, Carlsson E, Larsson H, Mattsson H. Hypergastrinemia after blockade of acid secretion in the rat: trophic effects. Digestion 1986; 35(Suppl 1)56–69
   PubMed Web of Science ®Google Scholar
• Larsson H, Carlsson E, Håkanson R, et al. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Gastroenterology 1988; 95: 1477–86
   PubMed Web of Science ®Google Scholar
• Axelson J, Håkanson R, Rosengren E, Sundler F. Hypergastrinemia induced by acid blockade evokes enterochromaffinlike (ECL) cell hyperplasia in chicken, hamster and guinea-pig stomach. Cell Tissue Res 1988; 254: 511–6
   PubMed Web of Science ®Google Scholar
• Koop H, Willemer S, Steinbach F, Eissele R, Tuch K, Arnold R. Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach in rats. Gastroenterology 1987; 92: 406–13
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W, Stöckmann F, Conlon J M, Fölsch U R, Bonatz G, Wiilfrath M. Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion 1986; 35(Suppl 1)84–97
   PubMed Web of Science ®Google Scholar
• Eissele R, Rosskopf B, Schmidt T, Koop H, Adler Arnold G. G. Time course of gastrin (G) and enterochromaffin (ECL) cell proliferation in drug-induced achlorhydria (Abstract). Digestion 1990; 46(Suppl 1)27
   PubMedGoogle Scholar
• Penston J, Wormsley KG. Achlorhydria: hyergastrinema: carcinoids. A flawed hypothesis? Gut 1987; 28: 488–505
   Web of Science ®Google Scholar
• Wormsley KG. Is chronic long-term inhibition of gastric secretion really dangerous?. Scand J Gastroenterol 1988; 23(Suppl 146)166–74
   Google Scholar
• Ryberg B, Axelson J, Håkanson R, Sundler F, Mattsson H. Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. Gastroenterology 1990; 98: 33–8
   PubMed Web of Science ®Google Scholar
• Tielemans Y, Håkanson R, Sundler F, Willems G. Proliferation of enterochromaffinlike cells in omeprazole-treated hyper-gastrinemic rats. Gastroenterology 1989; 96: 723–9
   PubMed Web of Science ®Google Scholar
• Ryberg B, Tielemans Y, Axelson J, et al. Gastrin stimulates the self replication rate of the enterochromaffin-like cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology 1990; 99: 935–42
   PubMed Web of Science ®Google Scholar
• Tielemans Y, Axelson J, Sundler F, Willems G, Håkanson R. Serum gastrin concentration affects the self replication of the enterochromaffin like cells in the rat stomach. Gut 1990; 31: 274–8
   PubMed Web of Science ®Google Scholar
• Tielemans Y, Willems G, Sundler F, Håkanson R. Self-replication of enterochromaffin-like cells in the mouse stomach. Digestion 1990; 45: 138–46
   PubMed Web of Science ®Google Scholar
• Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20(Suppl 108)53–69
   Google Scholar
• Poynter D, Pick C R, Harcourt R A, et al. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut 1985; 26: 1284–95
   PubMed Web of Science ®Google Scholar
• Ryberg B, Carlsson E, Carlsson K, et al. Effects of partial resection of acid-secreting mucosa on plasma gastrin and enterochromaffin-like cells in the rat stomach. Digestion 1990; 45: 102–8
   PubMed Web of Science ®Google Scholar
• Mattsson H, Havu N, Breutigam J, Carlsson K, Lundell L, Carlsson E. Partial gastric corpectomy results in hypergastrinemia and development of gastric ECL cell carcinoids in the rat. Gastroenterology 1991; 100: 311–9
   PubMed Web of Science ®Google Scholar
• Havu N, Mattsson H, Ekman L, Carlsson E. Enterochromaffinlike cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. Digestion 1990; 45: 189–95
   PubMed Web of Science ®Google Scholar
• Wallmark B, Skanberg I, Mattsson H, et al. Effect of 20 weeks' ranitidine treatment on plasma gastrin levels and gastric enterochromaffin-like cell density in the rat. Digestion 1990; 45: 181–8
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Liedberg G. Endocrine cell proliferation and carcinoid development: A review of new aspects of hyper-gastrinaemic atrophic gastritis. Digestion 1986; 35(Suppl I)106–14
   PubMedGoogle Scholar
• Wilander E, Nordgren H, Öberg K. Nonantral gastric carcinoid tumours associated with hypergastrinaemia. Acta Med Scand 1986; 219: 393–7
   PubMedGoogle Scholar
• Håkanson R, Sundler F. Gastric carcinoids and antisecretory drugs. TIPS 1986; 10: 386–7
   Google Scholar
• Bordi C, D'Adda T, Pilato F P, Ferrari C. Carcinoid (ECL cell) tumor of the oxyntic mucosa of the stomach: a hormone-dependent neoplasm?. Progress in surgical pathology, C Fenoglio-Preiser, M Wolff, F Rilke. Field & Wood, Philadelphia 1988; Vol. 8: 177–95
   Google Scholar
• Magnusson I, UvnäsMoberg K, Öst A. Gastric carcinoid tumours: endoscopic removal or gastric resection?. Acta Chir Scand 1986; 152: 707–8
   PubMedGoogle Scholar
• Richards A T, Hinder R A, Harrison AC. Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia-regression of tumours by antrectomy. S Afr Med J 1987; 72: 51–3
   PubMed Web of Science ®Google Scholar
• Eckhauser F E, Lloyd R V, Thompson N W, Raper S E, Vinik Al. Antrectomy for multicentric argyrophil gastric carcinoids: a preliminary report. Surgery 1988; 104: 1046–53
   PubMed Web of Science ®Google Scholar
• Lundell L, Olbe L, Sundler F, Simonsson M, Hakanson R. Reversibility of multiple ECL cell gastric carcinoids by antrectomy in a pernicious anemia patient (Abstract). Hepato-Gastroenterol 1989; 36: 43
   Google Scholar
• Hirschowitz B I, Griffith J, Pellegrin D, Cunnings OW. Rapid regression of ECL cell gastric carcinoids in 3 patients with pernicious anemia after elimination of hypergastrinemia by antrectomy (Abstract). Gastroenterology 1990; 98: 286
   Google Scholar
• Håkanson R, Bôttcher G, Ekblad E, et al. Histamine in endocrine cells in the stomach. Histochemistry 1986; 86: 5–17
   PubMedGoogle Scholar
• Lönroth H, Håkanson R, Lundell L, Sundler F. Histamine containing endocrine cells in the human stomach. Gut 1990; 31: 383–8
   PubMed Web of Science ®Google Scholar
• Schulak J A, Kaplan EL. Gastrin-induced hypocalcemia in thyroparathyroidectomized rats. Metabolism 1974; 23: 1103–6
   PubMed Web of Science ®Google Scholar
• Schulak J A, Kaplan EL. The importance of the stomach in gastrin-induced hypocalcemia in the rat. Endocrinology 1975; 96: 1217–20
   PubMed Web of Science ®Google Scholar
• Persson P, Grunditz T, Axelson J, Sundler F, Håkanson R. Cholecystokinins but not gastrin-17 release calcitonin from thyroid C cells in the rat. Regul Pept 1988; 21: 45–56
   PubMedGoogle Scholar
• Håkanson R, Persson P, Axelson J, Johnell O, Sundler F. Evidence that gastrin enhances 45Ca uptake into bone through release of a gastric hormone. Regul Pept 1990; 28: 107–18
   PubMedGoogle Scholar
• Persson P, Håkanson R, Axelson J, Sundler F. Gastrin releases a blood calcium-lowering peptide from the acid-producing part of the rat stomach. Proc Natl Acad Sci USA 1989; 86: 2834–8
   PubMed Web of Science ®Google Scholar
• Furness J B, Padbury R TA, Baimbridge K G, Skinner J M, Lawson D EM. Calbindin immunoreactivity is a characteristic of enterochromaffin-like cells (ECL cells)of the human stomach. Histochemistry 1989; 92: 449–51
   PubMedGoogle Scholar
• Sundler F, Bjartell A, Böttcher G, Ekblad E, Håkanson R. Coexistence of messengers in gut endocrine cells (Abstract). Biomed Res 1988; 7(Suppl. 1)6
   Google Scholar
• Ondolfo JPh, Lehy T, Labeille D, Grés L. Growth pattern of the polypeptide-YY cell population in the upper digestive tract of the rat during the perinatal period and after weaning. Cell Tissue Res 1989; 258: 569–76
   PubMed Web of Science ®Google Scholar
• Håkanson R, Böttcher G, Ekblad E, Grunditz T, Sundler F. Functional implications of messenger coexpression in neurons and endocrine cells. Neuropeptides and their receptors. Alfred Benzon Symp. 29., T W Schwartz, L Hilsted, J F Rehfeld. Munksgaard, Copenhagen 1990; 211–32
   Google Scholar
• Jessen K R, Hills J M, Llmbrick AR. GABA immunoreactivity and 3H-GABA uptake in mucosal epithelial cells of the rat stomach. Gut 1988; 29: 1549–56
   PubMed Web of Science ®Google Scholar
• Davanger S, Ottersen O P, Storm-Mathisen J. GABA-immunoreactive cells in the rat gastrointestinal epithelium. Anat Embryol 1989; 179: 221–6
   PubMedGoogle Scholar
• Feurle G E, Carraway R E, Rix E, Knauf W. Evidence for the presence of xenopsin-related peptide(s) in the gastric mucosa of mammals. J Clin Invest 1985; 76: 156–62
   PubMed Web of Science ®Google Scholar
• Rix E W, Feurle G E, Carraway RE. Co-localization of xenopsin and gastrin immunoreactivity in gastric antral G-cells. Histochemistry 1986; 85: 135–8
   PubMedGoogle Scholar
• Sundler F, Håkanson R, Leander S., Uddman R. Light and electron microscopic localization of neurotensin in the gastrointestinal tract. Ann NY Acad Sci 1982; 400: 94–103
   PubMed Web of Science ®Google Scholar
• Lamberts R, Schmidt W E, Creutzfeldt W. Light and electron microscopical immunocytochemical localization of pancreastatin-like immunoreactivity in porcine tissues. Histochemistry 1990; 93: 369–80
   PubMedGoogle Scholar
• Minamino N, Kangawa K, Matsuo H. Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun 1985; 130: 1078–85
   PubMed Web of Science ®Google Scholar
• Conlon J M, Domin J, Thim L, DiMarzo V, Morris H R, Bloom SR. Primary structure of neuromedin U from the rat. J Neurochem 1988; 51: 988–91
   PubMed Web of Science ®Google Scholar
• Minamino N, Kangawa K, Honzawa M, Matsuo H. Isolation and structural determination of rat neuromedin U. Biochem Biophys Res Commun 1988; 156: 355–60
   PubMed Web of Science ®Google Scholar
• Domin J, Ghatei M A, Chohan P, Bloom SR. Neuromedin U—A study of its distribution in the rat. Peptides 1987; 8: 779–84
   PubMed Web of Science ®Google Scholar
• Augood S J, Keast J R, Emson PC. Distribution and characterization of neuromedin U-like immunoreactivity in rat brain and intestine and in guinea pig intestine. Regul Pept 1988; 20: 281–92
   PubMedGoogle Scholar
• Ballesta J, Carlei F, Bishop A E, et al. Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 1988; 25: 797–816
   PubMed Web of Science ®Google Scholar
• Furness J B, Pompolo S, Murphy R, Giraud A. Projections of neurons with neuromedin U-like immunoreactivity in the small intestine of the guinea-pig. Cell Tissue Res 1989; 257: 415–22
   PubMed Web of Science ®Google Scholar
• Timmermans J-P, Scheuermann D W, Stach W, Adriaensen D, De Groodt-Lasseel M HA, Polak JM. Neuromedin U-immunoreactivity in the nervous system of the small intestine of the pig and its coexistence with substance P and CGRP. Cell Tissue Res 1989; 258: 331–7
   PubMed Web of Science ®Google Scholar
• Miyata A, Arimura A, Dahl RR. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 567–74
   PubMed Web of Science ®Google Scholar
• Miyata A, Jiang L, Dahl R D, et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 1990; 170: 643–8
   PubMed Web of Science ®Google Scholar
• Kimura C, Ohkubo S, Ogi K, et al. A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem Biophys Res Commun 1990; 166: 81–9
   PubMed Web of Science ®Google Scholar
• Köves K, Arimura A, Somogyvari-Vigh A, Vight S, Miller J. Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus. Endocrinology 1990; 127: 264–71
   PubMed Web of Science ®Google Scholar
• Sundler F, Ekblad E, Håkanson R, Köves K, Arimura A. Pituitary adenylate cyclase activating peptide (PACAP), a novel VIP-like gut neuropeptide (Abstract). Digestion 1990; 46(Suppl. I)111–2
   Google Scholar
• Brown D R, Quito FL. Neuromedin U octapeptide alters ion transport in porcine jejunum. Eur J Pharmacol 1988; 155: 159–62
   PubMed Web of Science ®Google Scholar
• Bockman C S, Abel P W, Hicks J W, Conlon JM. Evidence that neuromedin U may regulate gut motility in reptiles but not in mammals. Eur J Pharmacol 1989; 171: 255–7
   PubMed Web of Science ®Google Scholar
• Maggi C A, Patacchini R, Giuliani S, et al. Motor response of the human isolated small intestine and urinary bladder to porcine neuromedin U-8. Br J Pharmacol 1990; 99: 186–8
   PubMed Web of Science ®Google Scholar
• Gottschall P E, Tatsuno I, Miyata A, Arimura A. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology 1990; 127: 272–7
   PubMed Web of Science ®Google Scholar